Related Articles
Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
Dihydroartemisinin triggers c‑Myc proteolysis and inhibits protein kinase B/glycogen synthase kinase 3β pathway in T‑cell lymphoma cells
Dihydroartemisinin inhibits endothelial cell migration via the TGF‑β1/ALK5/SMAD2 signaling pathway
Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy